Tabula Rasa HealthCare Stock

Tabula Rasa HealthCare EBIT

Delisted

The EBIT of Tabula Rasa HealthCare (TRHC) as of Aug 24, 2026 is -67.91 M USD. In the previous year, EBIT was -69.32 M USD — a change of -2.03% (higher).

EBIT

-67.91 MUSD

YoY

-2.03%

Last updated:

In 2026, Tabula Rasa HealthCare's EBIT was -67.91 M USD, a -2.03% increase from the -69.32 M USD EBIT recorded in the previous year.

The Tabula Rasa HealthCare EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
-28.83 M USD
Jan 1, 2020
-57.74 M USD
Jan 1, 2021
-69.32 M USD
Jan 1, 2022
-67.91 M USD
Jan 1, 2023 (e)
-27.95 M USD
Jan 1, 2024 (e)
-23.36 M USD
Jan 1, 2025 (e)
-65.12 M USD
Jan 1, 2026 (e)
-6.61 M USD
The Tabula Rasa HealthCare EBIT history
YEAREBITYoY
est-6.61 MUSD-89.85%
est-65.12 MUSD+178.78%
est-23.36 MUSD-16.42%
est-27.95 MUSD-58.85%
-67.91 MUSD-2.03%
-69.32 MUSD+20.06%
-57.74 MUSD+100.25%
-28.83 MUSD+10,539.48%
-271,000.00USD-105.21%
5.20 MUSD+14.28%
4.55 MUSD-26.18%
6.17 MUSD+5,661.68%
107,000.00USD-104.30%
-2.49 MUSD
Access this data via the Eulerpool API

Tabula Rasa HealthCare Revenue

Tabula Rasa HealthCare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
284.71 M USD
-28.83 M USD
-32.44 M USD
Jan 1, 2020
297.22 M USD
-57.74 M USD
-80.97 M USD
Jan 1, 2021
331.26 M USD
-69.32 M USD
-79.06 M USD
Jan 1, 2022
299.52 M USD
-67.91 M USD
-77.33 M USD
Jan 1, 2023 (e)
362.20 M USD
-27.95 M USD
-971,740.00 USD
Jan 1, 2024 (e)
416.43 M USD
-23.36 M USD
6.07 M USD
Jan 1, 2025 (e)
468.89 M USD
-65.12 M USD
-6.56 M USD
Jan 1, 2026 (e)
403.19 M USD
-6.61 M USD
4,285.69 USD

Tabula Rasa HealthCare Margins

Tabula Rasa HealthCare stock margins

The Tabula Rasa HealthCare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tabula Rasa HealthCare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tabula Rasa HealthCare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
36.30 %
-10.13 %
-11.39 %
Jan 1, 2020
31.09 %
-19.43 %
-27.24 %
Jan 1, 2021
29.56 %
-20.93 %
-23.86 %
Jan 1, 2022
22.34 %
-22.67 %
-25.82 %
Jan 1, 2023 (e)
22.34 %
-7.72 %
-0.27 %
Jan 1, 2024 (e)
22.34 %
-5.61 %
1.46 %
Jan 1, 2025 (e)
22.34 %
-13.89 %
-1.40 %
Jan 1, 2026 (e)
22.34 %
-1.64 %
0.00 %

Tabula Rasa HealthCare Stock analysis

What does Tabula Rasa HealthCare do? Tabula Rasa HealthCare Inc is a US-based company specializing in the development of innovative healthcare solutions. The company was founded in 2009 by CEO and Chairman Calvin H. Knowlton and is headquartered in Moorestown, New Jersey. The business model of Tabula Rasa Healthcare offers a wide range of technology solutions focused on improving clinical processes and patient safety. These technology solutions are incorporated into its medication management programs and include electronic medication profiles and clinical decision support systems. By adding SinfoniaRx, Tabula Rasa HealthCare is able to provide a holistic approach to improving medication adherence and compliance. The company offers a broad range of services to enable efficient monitoring of medication effects. Tabula Rasa HealthCare's technology enables personalized medication delivery to ensure that each patient receives the right medication at the right time. Tabula Rasa HealthCare operates in three business divisions: medication safety, medication therapy management, and population health management. In the field of medication safety, the company provides solutions that enable medical personnel to conduct a comprehensive assessment of a patient's medical history and create an accurate medication list. The company also offers support for risk assessment and medication management in patients with multiple or complex chronic conditions. The medication therapy management division covers a range of individual measures aimed at monitoring medication therapies. Tabula Rasa HealthCare's solutions assist healthcare professionals in better understanding patients' medication and improving treatment outcomes. In the population health management field, the company offers tools and strategies for optimizing communicative data analysis to minimize patient requirements and healthcare costs. The company provides technology solutions to revolutionize patient care through the integration of data analytics and a focus on preventive measures. This helps patients achieve better treatment outcomes, detect diseases at an early stage, and save costs. In summary, Tabula Rasa HealthCare Inc is a company focused on developing technology solutions to improve medical decision-making and maximize patient safety. The company utilizes its expertise in various areas and provides customized solutions to ensure personalized and optimized medication delivery. Its business model includes a holistic approach to improving medication adherence and compliance. Tabula Rasa HealthCare is driving medical research and the development of technology solutions to revolutionize modern patient care. Tabula Rasa HealthCare is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Tabula Rasa HealthCare's EBIT

Tabula Rasa HealthCare's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Tabula Rasa HealthCare's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Tabula Rasa HealthCare's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Tabula Rasa HealthCare’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Tabula Rasa HealthCare stock

EBIT of Tabula Rasa HealthCare is -67.91 M USD in 2026.

EBIT of Tabula Rasa HealthCare changed from -69.32 M USD to -67.91 M USD, representing a -2.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Tabula Rasa HealthCare since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Tabula Rasa HealthCare historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Tabula Rasa HealthCare

All Key Metrics — Tabula Rasa HealthCare